Eli Lilly has launched Mounjaro in India, a groundbreaking weight loss and diabetes drug, at a fraction of its US price. The ...

Pharma giant Eli Lilly has launched Mounjaro, a popular weight-loss drug, in India. Priced at Rs 3,500 for 2.5 mg and Rs ...

Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

While the long term consequences vary, continuing a no protein diet would be life-threatening and not recommended.

As China embarks on its three-year "weight management" campaign, Novo Nordisk has stepped forward with its powerful tools to ...

Consumer Goods, GlobeNewswire, Product / Services Announcement | JUPITER, Fla., March 20, 2025 (GLOBE NEWSWIRE) -- The search ...

Laura Gaylord, DVM, DACVIM (Nutrition) shares the role of diet trials in chronic enteropathy patients during her lecture at ...

Many employers are facing challenges in incorporating high-cost GLP-1 medications, such as Mounjaro, Ozempic, Rybelsus, Trulicity, and Wegovy, ...

Lunch plays a crucial role in fueling your afternoon energy, stabilizing blood sugar, and supporting overall health. While ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

The demand for glucagon-like peptide 1 (GLP-1s) receptor agonists for overweight/obesity has created a clinical conundrum for ...

Eli Lilly and Company (India) has launched 'Mounjaro,' a novel medication for obesity and type 2 diabetes, after receiving ...